PIG Stock Overview
Provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Perrigo Company plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$25.25 |
52 Week High | US$31.00 |
52 Week Low | US$22.00 |
Beta | 0.48 |
11 Month Change | 13.89% |
3 Month Change | 1.00% |
1 Year Change | -7.27% |
33 Year Change | -29.86% |
5 Year Change | -42.09% |
Change since IPO | -77.33% |
Recent News & Updates
Recent updates
Shareholder Returns
PIG | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 1.7% | -6.3% | -0.6% |
1Y | -7.3% | -21.6% | 9.6% |
Return vs Industry: PIG exceeded the German Pharmaceuticals industry which returned -21.6% over the past year.
Return vs Market: PIG underperformed the German Market which returned 9.6% over the past year.
Price Volatility
PIG volatility | |
---|---|
PIG Average Weekly Movement | 4.2% |
Pharmaceuticals Industry Average Movement | 8.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PIG has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PIG's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1887 | 9,140 | Patrick Lockwood-Taylor | www.perrigo.com |
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Perrigo Company plc Fundamentals Summary
PIG fundamental statistics | |
---|---|
Market cap | €3.49b |
Earnings (TTM) | -€139.54m |
Revenue (TTM) | €4.17b |
0.8x
P/S Ratio-24.9x
P/E RatioIs PIG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PIG income statement (TTM) | |
---|---|
Revenue | US$4.39b |
Cost of Revenue | US$2.81b |
Gross Profit | US$1.58b |
Other Expenses | US$1.73b |
Earnings | -US$146.90m |
Last Reported Earnings
Sep 28, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.08 |
Gross Margin | 36.07% |
Net Profit Margin | -3.34% |
Debt/Equity Ratio | 104.8% |
How did PIG perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield-103%
Payout RatioDoes PIG pay a reliable dividends?
See PIG dividend history and benchmarksPerrigo dividend dates | |
---|---|
Ex Dividend Date | Nov 29 2024 |
Dividend Pay Date | Dec 17 2024 |
Days until Ex dividend | 13 days |
Days until Dividend pay date | 31 days |
Does PIG pay a reliable dividends?
See PIG dividend history and benchmarks